Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.2700
-0.0149 (-5.23%)
At close: Apr 1, 2025, 4:00 PM
0.2878
+0.0178 (6.59%)
After-hours: Apr 1, 2025, 7:32 PM EDT

Athira Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-96.94-117.67-95.64-54.85-19.96
Upgrade
Depreciation & Amortization
0.970.970.850.480
Upgrade
Loss (Gain) From Sale of Assets
0.01----
Upgrade
Loss (Gain) From Sale of Investments
-0.52-1.41-0.420.490.25
Upgrade
Stock-Based Compensation
11.0510.6210.614.620.63
Upgrade
Other Operating Activities
0.240.210.20.161.4
Upgrade
Change in Accounts Receivable
-1.231.11-1.04-1.3
Upgrade
Change in Accounts Payable
-5.757.372.15.152.6
Upgrade
Change in Unearned Revenue
-----1.5
Upgrade
Change in Other Net Operating Assets
-6.23-2.078.731.89-6.25
Upgrade
Operating Cash Flow
-97.17-100.75-72.47-43.1-24.11
Upgrade
Capital Expenditures
-0.03-0.3-1.14-1.57-2.32
Upgrade
Investment in Securities
54.8695.3958.81-2.51-207.78
Upgrade
Other Investing Activities
----0.04
Upgrade
Investing Cash Flow
54.8395.0957.66-4.08-210.07
Upgrade
Long-Term Debt Issued
----1.66
Upgrade
Net Debt Issued (Repaid)
----1.66
Upgrade
Issuance of Common Stock
0.190.490.6597.09209.16
Upgrade
Financing Cash Flow
0.190.490.6597.09292.75
Upgrade
Net Cash Flow
-42.15-5.17-14.1549.9158.57
Upgrade
Free Cash Flow
-97.2-101.06-73.61-44.67-26.43
Upgrade
Free Cash Flow Per Share
-2.53-2.66-1.95-1.21-2.21
Upgrade
Levered Free Cash Flow
-60.51-60.9-36.5-31.15-18.95
Upgrade
Unlevered Free Cash Flow
-60.51-60.9-36.5-31.15-18.72
Upgrade
Change in Net Working Capital
12.01-7.25-11.95-5.344.54
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q